Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Maskapai Reasuransi Indonesia Tbk (MREI.JK)
Jakarta Selatan, ID
PT Maskapai Reasuransi Indonesia Tbk functions as a dedicated reinsurance provider throughout Indonesia. The company's extensive portfolio includes general reinsurance offerings, covering property, motor vehicles, marine vessels and cargo, aviation, health, liability, personal accidents, suretyship, engineering, along with specialized solutions for the energy and oil & gas sectors. Additionally, it offers diverse life reinsurance products, encompassing term life, personal accident, financing life, credit life, critical illness, health, Hajj, and catastrophe protection. Established in 1953, the firm's primary operations are managed from its headquarters in South Jakarta, Indonesia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -2.96% | -7.08% | -13.60% | -1.50% | -18.60% | +43.80% | -72.79% | -80.10% | -89.06% | +706.85% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Reinsurance: +19.7%+12.2% Q3'25: +12.9% (vs Q3'24)
-
EPS growth Insurance - Reinsurance: +47.7%-17.2% Q3'25: +839.7% (vs Q3'24)
-
FCF margin FCF growth · Insurance - Reinsurance: +7.0%+2.3% Q3'25: +6.9% (vs Q3'24)
-
EBIT margin Insurance - Reinsurance: +13.4%+1.8% Q3'25: +3.6% (vs Q3'24)
-
ROIC Insurance - Reinsurance: +4.0%— Q3'25: -11.8% (vs Q3'24)
-
Share dilution Insurance - Reinsurance: +0.2%+0.0% Q3'25: +0.0% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Reinsurance: 0.00×0.00× ★ Q3'25: 0.00× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 2/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 2/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 2/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 2/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 2/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Adi Wirakusuma | Head of Treaty & Retrocession, Fac. Industrial, Risk Engineering | — | male |
| Agus Suryanto | Head of Information Technology Division | — | male |
| Aloysia Dwi Ana Nurhandayani AAAIK CPLHI | Head of Human Capital & General Affair, Director of Finance, Secretary & Commissioner | — | female |
| Anwar Cipto Syamsul AAAIK | Head of Claim Service & Loss Adjusting | — | male |
| Bagus Dena Pribadi | Head of Sharia Life Reinsurance Division | — | male |
| Fanra Budiman Arief | Head of Technical Life Reinsurance Division & Commissioner | — | male |
| Gunawan Wibisono | Head of Marketing Life Reinsurance Division | — | male |
| Paulus Muliawan | Head of Finance & Accounting Division and Acting Head of Investment Division | — | male |
| Purwani Kencana Warti | Company Actuary and Head of Administration & Claim Life Reinsurance | — | female |
| Robby Loho AAIK APAI CIIB CPIE Drs. ICBU ICPU | President Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MREI.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
